Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Miraca Life Sciences was a prominent U.S. provider of subspecialized anatomic and molecular pathology services, with a strong focus on gastroenterology, dermatology, hematology, urology, and breast health. The company was known for its high-quality diagnostic services, rapid turnaround times, and commitment to leveraging medical expertise for improved patient care. In 2017, Miraca Life Sciences was acquired by Inform Diagnostics (formerly CBLPath). Subsequently, Inform Diagnostics was acquired by Fulgent Genetics in April 2022. The legacy of Miraca Life Sciences continues within the specialized pathology services offered by Inform Diagnostics under Fulgent Genetics.
The headquarters housed key administrative, operational, laboratory, and research functions, coordinating the company's nationwide pathology services.
The facility likely included state-of-the-art laboratory spaces equipped for high-volume anatomic and molecular pathology testing, alongside corporate offices.
The work culture at Miraca Life Sciences would have emphasized scientific rigor, precision in diagnostics, collaboration among pathologists and staff, and a strong focus on patient outcomes and client service for physicians.
As the nerve center of its operations, the Irving headquarters was crucial for maintaining service quality, innovation in diagnostic capabilities, and managing its network of pathologists and laboratories across the U.S.
Miraca Life Sciences primarily operated within the United States. It was a subsidiary of Miraca Holdings Inc., a Japanese-based international healthcare company. While its direct pathology service operations were U.S.-focused, its parent company had a global footprint in clinical diagnostics and healthcare.
6655 North MacArthur Boulevard
Irving
Texas
USA
Address: Specific addresses are now part of the Inform Diagnostics network.
To ensure rapid turnaround times for diagnostic testing, provide localized client support to physicians and hospitals, and facilitate access to subspecialized pathology expertise in different regions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Miraca Life Sciences' leadership includes:
Miraca Life Sciences has been backed by several prominent investors over the years, including:
Miraca Life Sciences was acquired by Inform Diagnostics in 2017, which was subsequently acquired by Fulgent Genetics in 2022. Therefore, there have been no executive hires or exits attributable to 'Miraca Life Sciences' as an independent entity in the last 12 months. Any leadership changes would be within Inform Diagnostics or Fulgent Genetics.
Discover the tools Miraca Life Sciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition, Miraca Life Sciences likely used standard corporate email formats. Common patterns included first initial followed by last name, or first name dot last name, at their domain 'miracalifesciences.com'. These email addresses are no longer active.
[first_initial][last]@miracalifesciences.com
Format
jdoe@miracalifesciences.com
Example
0%
Success rate
PR Newswire • October 2, 2017
Inform Diagnostics announced its acquisition of Miraca Life Sciences, combining two leading anatomic pathology providers to create a larger, more comprehensive national pathology service with enhanced subspecialty expertise....more
Fulgent Genetics • April 19, 2022
Fulgent Genetics, Inc. announced the successful completion of its acquisition of Inform Diagnostics, thereby incorporating the legacy operations and expertise of Miraca Life Sciences into its broader genomic testing and pathology portfolio....more
Miraca Life Sciences Press Release (Archived) • August 10, 2015
Miraca Life Sciences Research Institute announced study results published in a leading gastroenterology journal, highlighting methods to improve the detection rates of sessile serrated adenomas/polyps, which are precursors to colorectal cancer....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Miraca Life Sciences, are just a search away.